China Pharma Holdings Inc. (CPHI)
NYSE · Healthcare
China Pharma Holdings Inc. Long Term Debt 2010–2025
China Pharma Holdings Inc. annual long term debt history from 2017 to 2020. Long term debt refers to financial obligations that are due more than one year in the future.
- China Pharma Holdings Inc. long term debt as of December 31, 2020: 5.2M, a 21.88% increase year-over-year.
- China Pharma Holdings Inc. long term debt for 2020 were 5.2M, a 21.88% increase from 2019.
- China Pharma Holdings Inc. long term debt for 2019 were 4.3M, a 34.29% decrease from 2018.
- China Pharma Holdings Inc. long term debt for 2018 were 6.5M, a 29.04% decrease from 2017.
- China Pharma Holdings Inc. long term debt for 2017 were 9.2M.
Long Term Debt
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| China Pharma Holdings Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2020 | $5 |
| 2019 | $4 |
| 2018 | $7 |
| 2017 | $9 |
China Pharma Holdings Inc. Long Term Debt — FAQ
China Pharma Holdings Inc. (CPHI) long term debt over the last 16 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CPHI's long term debt history?
The chart and table above show China Pharma Holdings Inc.'s long term debt by year and by quarter, including the growth rate.